Rubius Therapeutics Implied Volatility Movement
- ByInvesting.com-
Symbol | Exchange | Currency |
|---|
Rubius Therapeutics (NASDAQ:RUBY) reported Q2 EPS of ($0.49), $0.04 better than the analyst estimate of ($0.53).
Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Technology, Consumer Services and Healthcare sectors led shares higher. At the close in NYSE,...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced that the FDA has granted the company Investigational New Drug status for its gene therapy candidate, BMN 307 in patients with...
Rubius Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in developing a platform and pipeline that is focused on creating cellular medicines called Red Cell Therapeutics. The Company’s Red Cell Therapeutics are engineered to express biotherapeutic proteins within or on their cell surface to create selective and allogeneic cellular medicines for treating a range of diseases. Red Cell Therapeutics can also be used to kill tumors in cancer, regulate the immune system for the treatment of autoimmune diseases and treat a number of other types of illnesses. The Company’s subsidiary is Rubius Therapeutics Securities Corporation.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Neutral | Neutral | Neutral | Buy | Strong Sell |
| Summary | Sell | Sell | Sell | Neutral | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 6.76 | 6.77 | 6.41 | +0.410 | +6.46% | 212.12K | NYSE | |||
| 90.77 | 91.34 | 89.60 | +2.18 | +2.46% | 14.26M | NYSE | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 1.08K | OTC Markets | |||
| 22.59 | 22.99 | 22.46 | +0.07 | +0.31% | 12.80K | NYSE | |||
| 7.54 | 7.67 | 7.40 | +0.14 | +1.89% | 100.73K | NASDAQ | |||
| 24.99 | 24.9999 | 24.99 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 2.19 | 2.20 | 2.19 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 133.45 | 135.45 | 132.17 | +2.66 | +2.03% | 2.63M | NASDAQ | |||
| 4.60 | 4.60 | 4.40 | +0.2500 | +5.75% | 8.84K | NASDAQ | |||
| 8.52 | 8.68 | 8.45 | -0.010 | -0.12% | 388.03K | NASDAQ | |||
| 0.0021 | 0.0021 | 0.0021 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 69.54 | 72.00 | 69.36 | +0.45 | +0.65% | 9.28M | NASDAQ | |||
| 63.46 | 63.99 | 61.27 | +1.96 | +3.19% | 10.60M | NYSE | |||
| 9.01 | 15.29 | 8.75 | +1.42 | +18.71% | 55.25M | NASDAQ |